baber/WOPTO huggingface dataset:
Patent JP-3215474-B2 (JP)
IPC: A61B17/16
Filed: 1991-12-06
Granted: 2001-10-09
Abstract: The drill chuck, especially for a surgical drill (10), is designed as a quick-change chuck (30) and is preferably made as a unit of a material permeable to X-rays. Here, it is fastened to an angle attachment (12) of the drill (10) and consists of a chuck (31) carrying a drill bit (50), a grip sleeve (33) which surrounds the chuck (31) and can be displaced in the direction of the drilling axis (A), and at least one locking pin (34) which is arranged in the chuck (31) in such a way as to be displaceable to a limited extent transversely to the drilling axis (A) and which secures or releases the drill bit (50), carried in the chuck (31), by the longitudinal displacement of the grip sleeve (33). This quick-change chuck permits very quick and simple changing of a drill bit without the monitoring of the drilling progress on the video screen being impaired, which monitoring is made possible by X-rays. 
<IMAGE>
Patent JP-4672100-B2 (JP)
IPC: C08L25/06
Filed: 1999-12-22
Granted: 2011-04-20
Abstract: High transparency polymeric composition essentially consisting of:       (1) from 30 to 95% of polystyrene; (2) from 70% to 5% of a composition of vinylarene-conjugated diene block copolymers;  the percentage sum of (1) and (2) being equal to 100;  the composition (2) consisting of:   (2a) from 30 to 60% by weight of copolymers with a linear structure   (2b) from 70% to 40% by weight of copolymers with a branched structure; the weight average molecular weight of the above composition (2) ranging from 30,000 to 400,000, preferably from 50,000 to 200,000.
Patent JP-4315469-B2 (JP)
IPC: A61P3/00
Filed: 1997-06-03
Granted: 2009-08-19
Abstract: There is disclosed the use of mesembrine and related compounds (e.g. mesembranol, mesembranone) as scrotonin-uptake inhibitors, pharmaceutical compositions comprising such compounds or dry material or an extract of plants from the Mesembryanthemaceae family (e.g. Sceletium (Aizoaceae) tortuosum) containing a standardized content of said compounds, for use in the treatment of depressive states, psychological or psychiatric disorders with an anxiety component, alcohol and drug dependence, bulimia nervosa and obsessive-compulsive disorders. Also disclosed are new derivatives of mesembrine.
Patent JP-3555954-B2 (JP)
IPC: A61M39/18
Filed: 1995-06-28
Granted: 2004-08-18
Abstract: Methods for the sterile transfer of a solution are disclosed, including sterilizing the inlet to a connector by flowing a sterilizing fluid around the connector inlet, sterilizing a penetrating element for the connector by flowing a sterilizing solution around the penetrating element, and penetrating the sterilized inlet by the sterilized penetrating element in order to transfer the solution through the penetrating element on the connector. Apparatus for such sterile transfer of a solution is also provided.
Patent JP-4060358-B2 (JP)
IPC: B32B3/06
Filed: 1996-06-10
Granted: 2008-03-12
Abstract: A carpet structure and backing of superior dimensional stability and integrity which is especially useful in a free float system of installation. In one aspect of the invention, a carpet is provided having a selected dimensional stability in which there is (i) a first carpet part having a primary layer with pile substantially covering a first side of the layer, the pile tufted through the primary layer to leave tuft bundles on a second side of the primary layer and a binder encapsulating the tuft bundles, the first part having a predetermined force of expansion and contraction under cycling conditions of temperature and moisture; (ii) a second part in layered relationship to the first carpet part, the second carpet part constructed from one or more layers to have a predetermined resistance to expansion and contraction at least equal to or greater than the force of expansion and contraction of the first carpet part under cycling conditions of temperature and moisture and traffic loads on the carpet pile.
Patent JP-3953510-B2 (JP)
IPC: A61K31/727
Filed: 1994-06-16
Granted: 2007-08-08
Abstract: PCT No. PCT/SE94/00595 Sec. 371 Date Dec. 4, 1995 Sec. 102(e) Date Dec. 4, 1995 PCT Filed Jun. 16, 1994 PCT Pub. No. WO95/00152 PCT Pub. Date Jan. 5, 1995The present invention relates to pharmaceutical compositions containing heparin or heparin fragments or their derivatives in combination with one or more glycerol esters of at least one fatty acid as single absorption enhancer. The compositions are useful for oral administration, for administration through mucous membranes or for transdermal administration. The compositions will when necessary contain further physiologically acceptable additives, such as diluents and/or carriers, suitable for the adaptation to oral, buccal, rectal, sublingual, nasal, subcutaneous or transdermal administration. The composition according to the invention provide excellent absorption and bioavailability without employing additional enhancers or promoters.
Patent JP-H0692968-B2 (JP)
IPC: G01N33/52
Filed: 1988-02-29
Abstract: There is provided a biological diagnostic assay system wherein a phenoxy-substituted naphthalene compound, such as phenoxynaphthalene sulfonate, or a salt thereof, is utilized to prevent plasma proteins such as serum albumin from binding to other components of the assay and/or to displace plasma proteins which have become bound to other components of the assay.
Patent JP-H0438188-B2 (JP)
IPC: H04N5/14
Filed: 1984-10-22
Abstract: Noise reduction is achieved, without the introduction of noticeable artifacts in the displayed image, using (1) a non-ringing, non-aliasing, localized transfer, octave-band spectrum analyzer for separating the video signal representing the image into subspectra signals, (2) separate coring means for one or more of the analyzed subspectra signals, and (3) then a synthesizer employing one or more non-ringing, non-aliasing filters for deriving an output image-representing signal from all of the subspectra signals.
Patent JP-2598362-B2 (JP)
IPC: C12N5/08
Filed: 1992-01-15
Granted: 1997-04-09
Abstract: The present invention relates to a complex comprising hepatocyte growth factor (HGF) and met proto-oncogene protein. The present invention also relates to methods for detecting the presence of HGF ligand, met proto-oncogene receptor and methods for isolating either the ligand or receptor or complex comprising both. The present invention further relates to methods of diagnostic proliferative disorders and diseases such as hepatitis or hepatocarcinogenesis by detecting these ligand-receptor pairs.
Patent JP-3346562-B2 (JP)
IPC: A61P25/28
Filed: 1990-04-13
Granted: 2002-11-18
Abstract: The invention relates to methods for the treatment or prevention of neuronal loss in ischemia, hypoxia, hypoglycemia, brain and spinal cord trauma as well as for treatment of Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's disease, and Down's Syndrome by administering a pharmaceutical composition comprising an effective amount of 10,5-(iminomethano)-10,11-dihydro-5H-dibenzo[a,d]cycloheptene (IDDC) or derivatives thereof to an animal.
Patent JP-3634361-B2 (JP)
IPC: C07K14/705
Filed: 1993-10-01
Granted: 2005-03-30
Abstract: PCT No. PCT/SE93/00789 Sec. 371 Date Apr. 13, 1995 Sec. 102(e) Date Apr. 13, 1995 PCT Filed Oct. 1, 1993 PCT Pub. No. WO94/07920 PCT Pub. Date Apr. 14, 1994Molecular cloning and expression of a prostaglandin F2 alpha  receptor which is linked to the signal transduction pathways via guanine nucleotide binding regulatory (G) proteins and measured by, for example, cAMP, IP3 or intracellular calcium. By constructing cell lines that express a prostaglandin F2 alpha , receptor, the affinities and efficacies of agonist and antagonist drugs with the receptor can be assessed. A recombinant DNA construct includes a vector and a DNA fragment encoding a prostaglandin F2 alpha  receptor. A host cell is transformed with a recombinant DNA construct, so that the DNA fragment is expressed and a prostaglandin F2 alpha , receptor is produced. Suitable host systems include eukaryotic and prokaryotic cells, especially mamalian cells such as rat or human. Additionally, for diagnostic purposes, antibodies to a prostaglandin F2 alpha  receptor can be prepared by producing all or a portion of the receptor protein and injecting these into various types of mammals. Using the resulting antibodies, expression of an F2 alpha  receptor cDNA, i.e. receptor protein in tissue and cells can be measured.
Patent JP-2638173-B2 (JP)
IPC: C08G75/02
Filed: 1988-10-18
Granted: 1997-08-06
Abstract: A copoly(arylene sulfide) corresponding to the structure  [ (-A-S-)1-x(-A-S-S-)x] n wherein x is in the range of 0.5 to 0.001 and a process for its preparation by reacting a mixture of a diiodoaromatic compound and elemental sulfur.
Patent JP-2645264-B2 (JP)
IPC: F02M63/06
Filed: 1991-10-07
Granted: 1997-08-25
Abstract: The desired pressure wave for fuel ejection from the nozzle (ED) is generated when the return line from the blocking valve (ASV) is closed. During the subsequent stroke, fuel delivered by the piston (FK) of an e.m. pump is returned to the tank (T) until the armature spring returns the piston to its initial position, so that a non-return valve (RSV) admits fuel to the kinetic-to-potential energy conversion line (SL).
Patent JP-3676377-B2 (JP)
IPC: C09K3/14
Filed: 1996-11-18
Granted: 2005-07-27
Abstract: A process is provided that permits the rapid quenching of molten ceramics by passing a flow of the molten ceramic into a turbulent fluid flow such that the flow is broken up into particles which then solidify as they pass into and through a cyclone and are finally separated from the fluid flow and collected as dry particulate ceramic materials.
Patent JP-4032088-B2 (JP)
IPC: E05D11/00
Filed: 1997-03-14
Granted: 2008-01-16
Abstract: A device for use with a hinge in which two rigid elements (104, 105) may be placed in various relative angular positions, wherein the elongate part (109) to be protected and guided consists of a section or tube inserted through two mutually facing channels (111, 110) in respective ones of the rigid elements (104, 105). The device includes a movable member (107) arranged between said rigid elements (104, 105) and at least rotatably movable about a rotational axis of said hinge. The member further includes a hole (108) through which said elongate part (109) may inserted.
Patent JP-4404230-B2 (JP)
IPC: H01M50/574
Filed: 1997-04-10
Granted: 2010-01-27
Abstract: A current interrupt mechanism for electrochemical cells is disclosed. A thermally activated current interrupt mechanism is integrated into an end cap assembly for an electrochemical cell. The thermally responsive mechanism preferably includes a free floating bimetallic disk which deforms when exposed to elevated temperature causing a break in an electrical pathway within the end cap assembly. This prevents current from flowing through the cell and effectively shuts down an operating cell. Alternatively, the thermally responsive mechanism may include a meltable mass of material which melts when exposed to elevated temperature to break an electrical pathway within the end cap assembly. The end cap assembly may also include integrated therein a pressure responsive current interrupt mechanism. If the internal gas pressure within an operating cell exceeds a predetermined value, the pressure responsive mechanism activates to sever an electrical pathway within the end cap assembly to prevent current from passing through the cell. The pressure responsive mechanism may include a diaphragm which ruptures when there is extreme gas pressure buildup. Gas is allowed to escape from the cell interior to the external environment through a series of vent apertures within the end cap assembly.
Patent JP-4391598-B2 (JP)
IPC: A61K9/48
Filed: 1998-03-25
Granted: 2009-12-24
Abstract: A coated capsule is disclosed comprising a gelatin shell with a flavored coating. A sugar or sugar substitute is included in the material of the shell and that of the coating to stabilize both compositions and the junction therebetween.
Patent ES-2353103-B2 (ES)
Title: Método de mitigación de impacto visual.
Inventor: MANCHADO DEL VAL CRISTINA
IPC: G06F17/50
Filed: 2010-10-13
Granted: 2011-08-02
Abstract: Método de mitigación de impacto visual. 
     Un método para mitigar el impacto visual de una
obra de infraestructura, en el que, a partir de un modelo digital
del terreno (MDT), de una representación geométrica de la intrusión
visual (IV) causada por una obra de infraestructura en una zona de
observación, de una representación geométrica de dicha zona de
observación (PV) desde la que se visualiza dicha intrusión visual
(IV) y de una altura H de una posible barrera de mitigación a
levantar, se realizan las siguientes etapas: calcular numéricamente
una superficie (Sv) del lugar geométrico de los rayos visuales
trazados desde dicha zona de observación (PV) hasta dicha
representación geométrica de la intrusión visual (IV); calcular
numéricamente una superficie (So) desplazada de dicho modelo digital
del terreno (MDT) una distancia definida por dicha altura H;
encontrar todas las curvas de intersección (INT) de ambas
superficies (Sv, So); de toda la superficie abarcada por dichas
curvas de intersección (INT), delimitar la o las regiones en donde
dicha superficie desplazada (So) queda por encima de dicha
superficie del lugar geométrico de los rayos visuales (Sv), siendo
dicha región o regiones las zonas donde se consigue mitigar el
impacto visual de dicha obra de infraestructura con barreras de
altura H.
Patent ES-2560518-B2 (ES)
Title: Dispositivo de seguridad para la práctica de deportes en apnea
Inventor: VALERO OLMEDO FERNANDO
IPC: B63C9/125
Filed: 2014-07-21
Granted: 2016-11-07
Abstract: Dispositivo de seguridad para la práctica de deportes en apnea basado en un chaleco salvavidas que consta de unas cámaras de aire colocadas estratégicamente caracterizadas por una curvatura determinada, que permite que el inflando se produzca en tres etapas. De esta forma el sujeto puede rotar, frenar el descenso y ascender convenientemente.
Patent ES-2668788-B2 (ES)
Title: Sistema de construcción modular de una edificación
Inventor: FELIU RIUS TOMAS
IPC: E04B1/58
Filed: 2017-10-30
Granted: 2018-10-16
Abstract: Sistema de construcción modular de una edificación que comprende una primera estructura reticular que comprende una pluralidad de piezas principales (1) configuradas como vigas y como pilares que se unen perpendicularmente entre sí mediante una pluralidad de piezas de unión esquineras (8), al menos una segunda estructura que comprende unos bordes perimetrales, una pluralidad de piezas auxiliares (14) fijadas a las piezas principales (1), unas piezas de esquina (19) fijadas a las piezas principales (1) tal que entre las piezas auxiliares (14) y las piezas esquina (19) se crea al menos una canalización para alojar la segunda estructura, donde las segundas estructuras se fijan mediante las piezas de esquina (19) por los bordes perimetrales a la pluralidad de piezas principales (1) de la primera estructura, con las piezas principales (1) dispuestas en un mismo plano para cada segunda estructura.
Patent IE-S86116-B2 (IE)
Title: Hand sanitizer device
Inventor: CROWE JOHN
IPC: A47K5/00
Filed: 2012-02-21
Abstract: A hand sanitizer device for dispensing sanitizer material comprising: means for communicating across a data network; means for retaining a reservoir of sanitizer material; means for dispensing an adjustable amount of sanitizer material; and means for detecting when the amount of sanitizer material in the device is low; wherein the amount of sanitizer material dispensed by the means for dispensing may be adjusted remotely via the means for communicating across a data network.
Patent IE-S86459-B2 (IE)
Title: System for rotating a winding drum, windable closing screen and control method
Inventor: CARVALHEIRO EMMANUEL
IPC: E06B9/00
Filed: 2014-04-17
Abstract: This system (1) for rotating a windable drum (3) of a flexible apron (2) of a windable closing screen (P) comprises a direct current electric motor (70) comprising an output shaft (71) equipped with first rotational coupling means (73) and a movable member (9), movable relative to the drum (3), including second rotational coupling means. An electricity storage member powers the electric motor (70). The system further comprises first elastic means (11) that, by default, push (F) the movable member (9) into an engaged configuration, in which the rotational coupling means (73, 93) cooperate. A traction element (12) for pulling the movable element (9) allows to bring the movable member (9) into a disengaged configuration, in which the rotational coupling means (73, 93) are released. A compensating spring (13) exerts a torque that tends to drive the drum (3) against the weight of the apron (2). A control unit comprises means for detecting an obstacle by analysing the electric current of the motor. <Figure 1>
Patent AU-2001285835-B2 (AU)
Title: Device and method for raising an animal's hoof
Inventor: REISS SIEGFRIED
IPC: A01L3/06
Filed: 2001-07-12
Granted: 2005-06-02
Abstract: The invention relates to a device for raising the hoof of an animal such as a cow, comprising a shoe (24), such as a wooden block, to be fixed to the hoof. Said shoe can be fixed to the hoof by means of a connecting medium such as a single or multi-component adhesive. The invention enables the shoe to be fixed simply and unproblematically to the hoof, and any unevenness to be easily leveled out. In order to achieve this, a porous material comprising a reactive adhesive, or a component provided with or consisting of one such adhesive, is applied to the hoof-side surface (26) of the shoe (24), forming the connecting medium between the shoe and the hoof.
Patent AU-2001296608-B2 (AU)
Title: Compositions and methods for WT1 specific immunotherapy
Inventor: VEDVICK THOMAS S
IPC: A61K48/00
Filed: 2001-10-03
Granted: 2007-05-24
Abstract: Compositions and methods for the therapy of malignant diseases, such as leukemia and cancer, are disclosed. The compositions comprise one or more of a WT1 polynucleotide, a WT1 polypeptide, an antigen-presenting cell presenting a WT1 polypeptide, an antibody that specifically binds to a WT1 polypeptide; or a T cell that specifically reacts with a WT1 polypeptide. Such compositions may be used, for example, for the prevention and treatment of metastatic diseases.
Patent AU-2002232333-B2 (AU)
Title: Device for human protection in scaffolding
Inventor: WALLTHER HARRY
IPC: E04G5/00
Filed: 2002-02-13
Granted: 2007-11-15
Abstract: The present invention relates to a device for personal protection at such scaffolds that consist of scaffold posts (5, 6) and lying scaffold elements (7, 8, 15), coupled between the posts. The protective device consists of two protective post (26, 27) and a protective rail (32) with a variable length that extends between the protective posts. The protective rail is equipped with joint devices in their ends for a joined connection between the protective posts. The protective posts are equipped with coupling devices (28-31) for releasable connection with the scaffold. Thus the protective posts and the associated protective rail may gradually be moved between different vertical positions due to the need for protection.
Patent AU-2002329007-B2 (AU)
Title: "Probiotic Lactobacillus salivarius strains"
Inventor: O'MAHONY LIAM
IPC: A61K35/747
Filed: 2002-07-26
Granted: 2008-03-06
Abstract: A Lactobacillus salivarius strain, AH102, AH103, AH105, AH109 or AH110 or mutants or variants thereof are useful in the prophylaxis and/or treatment of inflammatory activity especially undesirable gastrointestinal inflammatory activity, such as inflammatory bowel disease or irritable bowel syndrome.
Patent AU-2002353736-B2 (AU)
Title: Post-modification of a porous support
Inventor: IHRE HENRIK
IPC: B01D15/08
Filed: 2002-11-26
Granted: 2008-05-08
Abstract: The present invention relates to a method for post-modification of a porous polymeric polysaccharide support comprising one or more unreacted double bonds, which method includes to contact the polymeric support with a liquid phase comprising at least one grafting compound and to initiate a free radical reaction in the mixture obtained, wherein the grafting compound is comprised of a double bond as a reactive group coupled to a linear or cyclic chain of carbon, which optionally comprises one or more heteroatoms. An advantageous grafting compound is a vinyl ether or a hydroxyvinyl ether. The invention also encompasses a polymeric support that has been post-modified by the method according to the invention as well as the use of such a support, e.g. in chromatography.
Patent AU-2003269903-B2 (AU)
Title: Assays for assembly of ebola virus nucleocapsids
Inventor: NABEL GARY
IPC: C12Q1/70
Filed: 2003-07-11
Granted: 2009-07-23
Abstract: The present invention relates to assays for the identification of compounds that inhibit assembly of NP, VP35, and VP24, or inhibit the glycosylation of NP, required for nucleocapsid formation, for use as anti-viral agents. The invention also relates to assays for the identification of compounds that block glycosylation of proteins having a glycosylation domain that is substantially homologous to a glycosylation domain of NP required for polymerization. The invention further relates to pseudoparticles for presentation of antigens or antigenic epitopes for immunogenic or vaccination purposes.
Patent AU-2004224157-B2 (AU)
Title: pH-dependent polypeptide aggregation and its use
Inventor: ZAHN RALPH
IPC: C07K14/47
Filed: 2004-03-23
Granted: 2007-02-08
Abstract: The invention provides an alternative method of reversible aggregation and/or dissociation of polypeptides. Proteins or polypeptides according to the invention have an inherent aggregation capability, wherein the aggregation is an oligomerization of the polypeptide that is based on the presence and the strucuture of peptide repeats localized in a flexibly disordered domain of this polypeptide. The flexibly disordered domain comprising the peptide repeats preferrably is located in close proximity with the N-terminus of the protein amino acid sequence. Preferably, each of the peptide repeats has a sequence that comprises one to four identical octapeptides with the amino acid sequence: PHGGGWGQ. Preferred proteins are selected from the group comprising cellular prion proteins (PrP<C>) and engineered polypeptides or fusion proteins with a respective inherent reversible aggregation and dissociation capability. Because of the new mechanism of aggregation, the oligomerization reaction of the protein is reversible in a fluidic environment depending on the pH of this fluidic environment. Oligomerization occurs at a pH of 6.2 to 7.8, and the dissociation into monomers is reported to be at a pH range of 4.5 to 5.5.
Patent AU-2004232941-B2 (AU)
Title: Piperazine containing phosphonic acid compounds as inhibitors of serine proteases
Inventor: SORGI KIRK LEONARD
IPC: C07F9/655
Filed: 2004-04-14
Granted: 2011-07-28
Abstract: The present invention is directed to phosphonic acid compounds useful as serine protease inhibitors, compositions thereof and methods for treating inflammatory and serine protease mediated disorders.
Patent AU-2004295204-B2 (AU)
Title: Cutting insert for grooving operations
Inventor: GATI UZI
IPC: B23B27/00
Filed: 2004-11-14
Granted: 2009-08-20
Abstract: A cutting insert for grooving operations having a forward main cutting edge and two opposing side cutting edges extending rearwardly and outwardly from the main cutting edge, each side cutting edge having a variable rake angle.